About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [1,833 citations: 101–200 of 1,739 articles]

Articles published in Advances in Hematology have been cited 1,833 times. The following is a list of the 1,739 articles that have cited the articles published in Advances in Hematology.

  • Liang Liang, Ming Zhao, Yuan-chao Zhu, Xin Hu, Li-ping Yang, and Hui Liu, “Efficacy of lenalidomide in relapsed/refractory chronic lymphocytic leukemia patient: a systematic review and meta-analysis,” Annals of Hematology, 2016. View at Publisher · View at Google Scholar
  • Fei Qi, Mei Dong, Xiaohui He, Yexiong Li, Weihu Wang, Peng Liu, Jianliang Yang, Lin Gui, Changgong Zhang, Sheng Yang, Shengyu Zhou, and Yuankai Shi, “Gemcitabine, dexamethasone, and cisplatin (GDP) as salvage chemotherapy for patients with relapsed or refractory peripheral T cell lymphoma—not otherwise specified,” Annals of Hematology, 2016. View at Publisher · View at Google Scholar
  • Keichiro Mihara, Naomi Sasaki, Ooeda Mamoru, Masayuki Kanbe, Tatsuo Ichinohe, and Shinichi Suehiro, “Solitary plasmablastic lymphoma in the esophagus,” Annals of Hematology, 2016. View at Publisher · View at Google Scholar
  • E. M. P. Cremers, A. van Biezen, L. C. de Wreede, M. Scholten, A. Vitek, J. Finke, U. Platzbecker, D. Beelen, R. Schwerdtfeger, L. Volin, N. Harhalakis, N. Blijlevens, A. Nagler, N. Kröger, and T. de Witte, “Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the CMWP of the EBMT,” Annals of Hematology, 2016. View at Publisher · View at Google Scholar
  • M. Malvezzi, G. Carioli, P. Bertuccio, T. Rosso, P. Boffetta, F. Levi, C. La Vecchia, and E. Negri, “European cancer mortality predictions for the year 2016 with focus on leukaemias,” Annals of Oncology, pp. mdw022, 2016. View at Publisher · View at Google Scholar
  • P. Musto, K. C. Anderson, M. Attal, P. G. Richardson, A. Badros, J. Hou, R. Comenzo, J. Du, B. G. M. Durie, J. San Miguel, H. Einsele, W. M. Chen, L. Garderet, G. Pietrantuono, J. Hillengass, R. A. Kyle, P. Moreau, J. J. Lahuerta, O. Landgren, H. Ludwig, A. Larocca, A. Mahindra, M. Cavo, A. Mazumder, P. L. McCarthy, A. Nouel, S. V. Rajkumar, A. Reiman, E. R. Serra, O. Sezer, E. Terpos, I. Turesson, S. Usmani, B. M. Weiss, and A. Palumbo, “Second primary malignancies in multiple myeloma: an overview and IMWG consensus,” Annals of Oncology, pp. mdw606, 2016. View at Publisher · View at Google Scholar
  • Antoine N. Saliba, and Ali T. Taher, “Morbidities in non-transfusion-dependent thalassemia,” Annals of the New York Academy of Sciences, vol. 1368, no. 1, pp. 82–94, 2016. View at Publisher · View at Google Scholar
  • Thomas D. Coates, Susan Carson, John C. Wood, and Vasilios Berdoukas, “Management of iron overload in hemoglobinopathies: what is the appropriate target iron level?,” Annals of the New York Academy of Sciences, vol. 1368, no. 1, pp. 95–106, 2016. View at Publisher · View at Google Scholar
  • Gideon Gross, and Zelig Eshhar, “Therapeutic Potential of T Cell Chimeric Antigen Receptors (CARs) in Cancer Treatment: Counteracting Off-Tumor Toxicities for Safe CAR T Cell Therapy,” Annual Review of Pharmacology and Toxicology, vol. 56, no. 1, pp. 59–83, 2016. View at Publisher · View at Google Scholar
  • Amandeep Kaur, Karolina Jankowska, Chelsea Pilgrim, Stuart T. Fraser, and Elizabeth J. New, “Studies of Hematopoietic Cell Differentiation with a Ratiometric and Reversible Sensor of Mitochondrial Reactive Oxygen Species,” Antioxidants & Redox Signaling, 2016. View at Publisher · View at Google Scholar
  • Mónica Varela, Antonio Figueras, and Beatriz Novoa, “Modelling viral infections using zebrafish: Innate immune response and antiviral research,” Antiviral Research, 2016. View at Publisher · View at Google Scholar
  • Yuan-Chin Lee, Ying-Jung Chen, Chia-Hui Huang, and Long-Sen Chang, “Amsacrine-induced apoptosis of human leukemia U937 cells is mediated by the inhibition of AKT- and ERK-induced stabilization of MCL1,” Apoptosis, 2016. View at Publisher · View at Google Scholar
  • TuDung T. Nguyen, John L. Frater, Jonathan Klein, Ling Chen, Nancy L. Bartlett, Kelley V. Foyil, and Friederike H. Kreisel, “Expression of TIA1 and PAX5 in Classical Hodgkin Lymphoma at Initial Diagnosis May Predict Clinical Outcome,” Applied Immunohistochemistry & Molecular Morphology, vol. 24, no. 6, pp. 383–391, 2016. View at Publisher · View at Google Scholar
  • Megan L. Troxell, and Christian Lanciault, “Practical Applications in Immunohistochemistry: Evaluation of Rejection and Infection in Organ Transplantation,” Archives of Pathology & Laboratory Medicine, vol. 140, no. 9, pp. 910–925, 2016. View at Publisher · View at Google Scholar
  • Jasmine Tay, Jim Tiao, Quintin Hughes, Grace Gilmore, and Ross Baker, “Therapeutic Potential of miR-494 in Thrombosis and Other Diseases: A Review,” Australian Journal of Chemistry, vol. 69, no. 10, pp. 1078, 2016. View at Publisher · View at Google Scholar
  • Saar Gill, “Chimeric antigen receptor T-cell therapy in AML: How close are we?,” Best Practice & Research Clinical Haematology, 2016. View at Publisher · View at Google Scholar
  • Adriana Borriello, Ilaria Caldarelli, Maria Carmela Speranza, Saverio Scianguetta, Annunziata Tramontano, Debora Bencivenga, Emanuela Stampone, Aide Negri, Bruno Nobili, Franco Locatelli, Silverio Perrotta, Adriana Oliva, and Fulvio Della Ragione, “Iron overload enhances human mesenchymal stromal cell growth and hampers matrix calcification,” Biochimica et Biophysica Acta (BBA) - General Subjects, vol. 1860, no. 6, pp. 1211–1223, 2016. View at Publisher · View at Google Scholar
  • Neuza Domingues, Luís M.B.B. Estronca, João Silva, Marisa R. Encarnação, Rita Mateus, Diogo Silva, Inês B. Santarino, Margarida Saraiva, Maria I.L. Soares, Teresa M.V.D. Pinho e Melo, António Jacinto, Winchil L.C. Vaz, and Otília V. Vieira, “Cholesteryl hemiesters alter lysosome structure and function and induce proinflammatory cytokine production in macrophages,” Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2016. View at Publisher · View at Google Scholar
  • Sabine Matou-Nasri, Zaki Rabhan, Haya Al-Baijan, Hamad Al-Eidi, Wesam Bin Yahya, Abdelkareem Al Abdulrahman, Nasser Almobadel, Mona Alsubeai, Saleh Al Ghamdi, Ahmed Alaskar, Mohammed AlBalwi, Mohsen Alzahrani, and Ibrahim Alabdulkareem, “CD95-mediated apoptosis in Burkitt's lymphoma B-cells is associated with Pim-1 down-regulation,” Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2016. View at Publisher · View at Google Scholar
  • Mohammed M. H. Al-Gayyar, Ahmed Abbas, and Ahmed M. Hamdan, “Chemopreventive and hepatoprotective roles of adiponectin (SULF2 inhibitor) in hepatocelluar carcinoma,” Biological Chemistry, vol. 397, no. 3, pp. 257–267, 2016. View at Publisher · View at Google Scholar
  • Sarita Rani Jaiswal, Shamsur Zaman, Aditi Chakrabarti, Subrata Sen, Shashwata Mukherjee, Sneh Bhargava, Kunal Ray, Paul V. O'Donnell, and Suparno Chakrabarti, “Improved Outcome of Refractory/Relapsed Acute Myeloid Leukemia after Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation with Myeloablative Conditioning and Early Prophylactic Granulocyte Colony-Stimulating Factor–Mobilized Donor Lymphocyte Infusions,” Biology of Blood and Marrow Transplantation, 2016. View at Publisher · View at Google Scholar
  • Dharshan Sivaraj, Michael M Green, Zhiguo Li, Anthony D Sung, Stefanie Sarantopoulos, Yubin Kang, Gwynn D Long, Mitchell E Horwitz, Richard D Lopez, Keith M Sullivan, David A Rizzieri, Nelson J Chao, and Cristina Gasparetto, “Outcomes of Maintenance Therapy with Bortezomib Post-Autologous Stem Cell Transplantation for Patients with Multiple Myeloma,” Biology of Blood and Marrow Transplantation, 2016. View at Publisher · View at Google Scholar
  • Orly R. Klein, Jessica Buddenbaum, Noah Tucker, Allen R. Chen, Christopher J. Gamper, David Loeb, Elias Zambidis, Nicolas J. Llosa, Jeffrey S. Huo, Nancy Robey, Mary Jo Holuba, Yvette L. Kasamon, Shannon R. McCurdy, Richard Ambinder, Javier Bolaños-Meade, Leo Luznik, Ephraim J. Fuchs, Richard J. Jones, Kenneth R. Cooke, and Heather J. Symons, “Nonmyeloablative Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide for Pediatric and Young Adult Patients with High-Risk Hematologic Malignancies,” Biology of Blood and Marrow Transplantation, 2016. View at Publisher · View at Google Scholar
  • Carmem Bonfim, Lisandro Ribeiro, Samantha Nichele, Gisele Loth, Marco Bitencourt, Adriana Koliski, Cilmara Kuwahara, Ana Luiza Fabro, Noemi F. Pereira, Daniela Pilonetto, Monica Thakar, Hans-Peter Kiem, Kristin Page, Ephraim J Fuchs, Mary Eapen, and Ricardo Pasquini, “Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Children and Adolescents with Fanconi Anemia,” Biology of Blood and Marrow Transplantation, 2016. View at Publisher · View at Google Scholar
  • Anne S Renteria, John E Levine, and James L Ferrara, “Development of a biomarker scoring system for use in graft-versus-host disease,” Biomarkers in Medicine, 2016. View at Publisher · View at Google Scholar
  • Rhythm R. Shah, Taylor W. Linville, Andrew D. Whynot, and Christopher S. Brazel, “Evaluating the toxicity of bDtBPP on CHO-K1 cells for testing of single-use bioprocessing systems considering media selection, cell culture volume, mixing, and exposure duration,” Biotechnology Progress, 2016. View at Publisher · View at Google Scholar
  • Salvador Alandete, Maria Dolores Monedero, M Angeles Meseguer, and Fructuoso Delgado, “What is that? HIV-negative plasmablastic lymphoma with intramuscular masses,” BJR|case reports, pp. 20150211, 2016. View at Publisher · View at Google Scholar
  • Alessandro M. Vannucchi, and Claire N. Harrison, “Emerging treatments for classical myeloproliferative neoplasms,” Blood, vol. 129, no. 6, pp. 693–703, 2016. View at Publisher · View at Google Scholar
  • C. Casu, P. R. Oikonomidou, H. Chen, V. Nandi, Y. Ginzburg, P. Prasad, R. E. Fleming, Y. M. Shah, E. V. Valore, E. Nemeth, T. Ganz, B. MacDonald, and S. Rivella, “Minihepcidin peptides as disease modifiers in mice affected by  -thalassemia and polycythemia vera,” Blood, vol. 128, no. 2, pp. 265–276, 2016. View at Publisher · View at Google Scholar
  • R. Zeiser, and B. R. Blazar, “Preclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation?,” Blood, vol. 127, no. 25, pp. 3117–3126, 2016. View at Publisher · View at Google Scholar
  • Dipica Haribhai, Xiaofeng Luo, Juan Chen, Shuang Jia, Linzheng Shi, Jocelyn A. Schroeder, Hartmut Weiler, Richard H. Aster, Martin J. Hessner, Jianda Hu, Calvin B. Williams, and Qizhen Shi, “TGF-β1 along with other platelet contents augments Treg cells to suppress anti-FVIII immune responses in hemophilia A mice,” Blood Advances, vol. 1, no. 2, pp. 139–151, 2016. View at Publisher · View at Google Scholar
  • M Cartellieri, A Feldmann, S Koristka, C Arndt, S Loff, A Ehninger, M von Bonin, E P Bejestani, G Ehninger, and M P Bachmann, “Switching CAR T cells on and off: a novel modular platform for retargeting of T cells to AML blasts,” Blood Cancer Journal, vol. 6, no. 8, pp. e458, 2016. View at Publisher · View at Google Scholar
  • L He, H-Y Zhu, S-C Qin, Y Li, Y Miao, J-H Liang, Y Xia, Y Wang, Y-J Wu, L Wang, L Fan, J-Y Li, and W Xu, “Low natural killer (NK) cell counts in peripheral blood adversely affect clinical outcome of patients with follicular lymphoma,” Blood Cancer Journal, vol. 6, no. 8, pp. e457, 2016. View at Publisher · View at Google Scholar
  • K-H Lim, Y-C Chang, Y-H Chiang, H-C Lin, C-Y Chang, C-S Lin, L Huang, W-T Wang, C Gon-Shen Chen, W-C Chou, and Y-Y Kuo, “Expression of CALR mutants causes mpl-dependent thrombocytosis in zebrafish,” Blood Cancer Journal, vol. 6, no. 10, pp. e481, 2016. View at Publisher · View at Google Scholar
  • Laura Sonzogni, Luisa Ronzoni, Giovanna Graziadei, and Maria Domenica Cappellini, “Ferroportin expression and regulation in non-transfusion dependent thalassemia,” Blood Cells, Molecules, and Diseases, 2016. View at Publisher · View at Google Scholar
  • Ari Zimran, Deborah Elstein, Derlis E. Gonzalez, Elena A. Lukina, Yulin Qin, Quinn Dinh, and Hadhami Ben Turkia, “Treatment-naïve Gaucher disease patients achieve therapeutic goals and normalization with velaglucerase alfa by 4years in phase 3 trials,” Blood Cells, Molecules, and Diseases, 2016. View at Publisher · View at Google Scholar
  • Kosha Mehta, Mark Busbridge, Derek Renshaw, Robert W. Evans, Sebastien Farnaud, and Vinood B. Patel, “Characterization of hepcidin response to holotransferrin in novel recombinant TfR1 HepG2 cells,” Blood Cells, Molecules, and Diseases, vol. 61, pp. 37–45, 2016. View at Publisher · View at Google Scholar
  • Alessandro Allegra, Vanessa Innao, Demetrio Gerace, Doriana Vaddinelli, and Caterina Musolino, “Adoptive immunotherapy for hematological malignancies: Current status and new insights in chimeric antigen receptor T cells,” Blood Cells, Molecules, and Diseases, 2016. View at Publisher · View at Google Scholar
  • Peng Wan, Min Yu, Min Qian, Huasheng Tong, and Lei Su, “Sonoclot coagulation analysis,” Blood Coagulation & Fibrinolysis, vol. 27, no. 1, pp. 77–83, 2016. View at Publisher · View at Google Scholar
  • Seham M. Ragab, and Mohamed A. Soliman, “Tissue factor-positive monocytes expression in children with sickle cell disease,” Blood Coagulation & Fibrinolysis, vol. 27, no. 8, pp. 862–869, 2016. View at Publisher · View at Google Scholar
  • Queenie Fernandes, “MicroRNA: Defining a new niche in Leukemia,” Blood Reviews, 2016. View at Publisher · View at Google Scholar
  • Elizabeth D. Hutchins, Walter L. Eckalbar, Justin M. Wolter, Marco Mangone, and Kenro Kusumi, “Differential expression of conserved and novel microRNAs during tail regeneration in the lizard Anolis carolinensis,” Bmc Genomics, vol. 17, 2016. View at Publisher · View at Google Scholar
  • Eyuel Kassa, Bamlaku Enawgaw, Aschalew Gelaw, and Baye Gelaw, “Effect of anti-tuberculosis drugs on hematological profiles of tuberculosis patients attending at University of Gondar Hospital, Northwest Ethiopia,” BMC Hematology, vol. 16, no. 1, 2016. View at Publisher · View at Google Scholar
  • Yang Wan, Qian Zhang, Zhaojun Zhang, Binfeng Song, Xiaomin Wang, Yingchi Zhang, Qiong Jia, Tao Cheng, Xiaofan Zhu, Anskar Yu-Hung Leung, Weiping Yuan, Haibo Jia, and Xiangdong Fang, “Transcriptome analysis reveals a ribosome constituents disorder involved in the RPL5 downregulated zebrafish model of Diamond-Blackfan anemia,” BMC Medical Genomics, vol. 9, no. 1, 2016. View at Publisher · View at Google Scholar
  • Rashika Chand, Harish Chandra, Smita Chandra, and Sanjiv Kumar Verma, “Role of Microvessel Density and Vascular Endothelial Growth Factor in Angiogenesis of Hematological Malignancies,” Bone Marrow Research, vol. 2016, pp. 1–4, 2016. View at Publisher · View at Google Scholar
  • M Byrne, and B N Savani, “The devil is in the T cells: relapsing after haploidentical hematopoietic cell transplantation,” Bone Marrow Transplantation, 2016. View at Publisher · View at Google Scholar
  • M Slade, B Fakhri, B N Savani, and R Romee, “Halfway there: the past, present and future of haploidentical transplantation,” Bone Marrow Transplantation, 2016. View at Publisher · View at Google Scholar
  • T L Bahr, T Lund, N M Sando, P J Orchard, and W P Miller, “Haploidentical transplantation with post-transplant cyclophosphamide following reduced-intensity conditioning for osteopetrosis: outcomes in three children,” Bone Marrow Transplantation, 2016. View at Publisher · View at Google Scholar
  • E. Van den Neste, N. Schmitz, N. Mounier, D. Gill, D. Linch, M. Trneny, N. Milpied, J. Radford, N. Ketterer, O. Shpilberg, U. Duehrsen, D. Ma, J. Briere, C. Thieblemont, G. Salles, C. H. Moskowitz, B. Glass, and C. Gisselbrecht, “Outcome of patients with relapsed diffuse large B-cell lymphoma who fail second-line salvage regimens in the International CORAL study,” Bone Marrow Transplantation, vol. 51, no. 1, pp. 51–57, 2016. View at Publisher · View at Google Scholar
  • R P Gale, and E J Fuchs, “Is there really a specific graft-versus-leukaemia effect?,” Bone Marrow Transplantation, 2016. View at Publisher · View at Google Scholar
  • A Rashidi, M Slade, J F DiPersio, P Westervelt, R Vij, and R Romee, “Post-transplant high-dose cyclophosphamide after HLA-matched vs haploidentical hematopoietic cell transplantation for AML,” Bone Marrow Transplantation, 2016. View at Publisher · View at Google Scholar
  • Christoph Domschke, Andreas Schneeweiss, Stefan Stefanovic, Markus Wallwiener, Joerg Heil, Joachim Rom, Christof Sohn, Philipp Beckhove, and Florian Schuetz, “Cellular Immune Responses and Immune Escape Mechanisms in Breast Cancer: Determinants of Immunotherapy,” Breast Care, vol. 11, no. 2, pp. 102–107, 2016. View at Publisher · View at Google Scholar
  • Lise Fischer Henriksen, Anne-Sofie Petri, Hans Carl Hasselbalch, Jørgen Kim Kanters, and Christina Ellervik, “Increased iron stores prolong the QT interval - a general population study including 20 261 individuals and meta-analysis of thalassaemia major,” British Journal of Haematology, 2016. View at Publisher · View at Google Scholar
  • Rayne H. Rouce, Sandhya Sharma, Mai Huynh, and Helen E. Heslop, “Recent advances in T-cell immunotherapy for haematological malignancies,” British Journal of Haematology, 2016. View at Publisher · View at Google Scholar
  • Damien Guinault, Emmanuel Canet, Antoine Huart, Arnaud Jaccard, David Ribes, Laurence Lavayssiere, Marion Venot, Olivier Cointault, Murielle Roussel, Marie-Béatrice Nogier, Claire Pichereau, Virginie Lemiale, Bertrand Arnulf, Michel Attal, Dominique Chauveau, Elie Azoulay, and Stanislas Faguer, “Short- and long-term outcomes of AL amyloidosis patients admitted into intensive care units,” British Journal of Haematology, 2016. View at Publisher · View at Google Scholar
  • John B. Porter, Maria Domenica Cappellini, Antonis Kattamis, Vip Viprakasit, Khaled M. Musallam, Zewen Zhu, and Ali T. Taher, “Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions,” British Journal of Haematology, 2016. View at Publisher · View at Google Scholar
  • Elizabeth Molyneux, Ed Schwalbe, George Chagaluka, Kondwani Banda, Trijn Israels, Sarita Depani, Kirstin Mittermayer-Vassallo, Kevin Windebank, Jessie Mvula, Jenala Njiram'madzi, Stephen O'Brien, Peter Carey, and Simon Bailey, “The use of anthracyclines in the treatment of endemic Burkitt lymphoma,” British Journal of Haematology, 2016. View at Publisher · View at Google Scholar
  • Zhihua Jiang, Hong-yuan Luo, Shengwen Huang, John J. Farrell, Lance Davis, Roger Théberge, Katherine A. Benson, Suchada Riolueang, Vip Viprakasit, Nasir A.S. Al-Allawi, Sule Ünal, Fatma Gümrük, Nejat Akar, A. Nazli Başak, Leonor Osorio, Catherine Badens, Serge Pissard, Philippe Joly, Andrew D. Campbell, Patrick G. Gallagher, Martin H. Steinberg, Bernard G. Forget, and David H.K. Chui, “ The genetic basis of asymptomatic codon 8 frame-shift ( HBB :c25_26delAA) β 0 -thalassaemia homozygotes ,” British Journal of Haematology, 2016. View at Publisher · View at Google Scholar
  • Bruce Shiramizu, Lara Mussolin, Wilhelm Woessmann, and Wolfram Klapper, “Paediatric non-Hodgkin lymphoma - perspectives in translational biology,” British Journal of Haematology, 2016. View at Publisher · View at Google Scholar
  • Cécile Jovelet, Sophie Broutin, Sophie Gil, Olivier Mir, and Angelo Paci, “Inhibiteurs de tyrosine kinase et grossesse : quels risques pour le fœtus ?,” Bulletin du Cancer, 2016. View at Publisher · View at Google Scholar
  • Marion Cornish, Michael B. Butler, and Robert S. Green, “Predictors of Poor Outcomes in Critically Ill Adults with Hematologic Malignancy,” Canadian Respiratory Journal, vol. 2016, pp. 1–7, 2016. View at Publisher · View at Google Scholar
  • Theresa H.M. Keegan, Lynn A.G. Ries, Ronald D. Barr, Ann M. Geiger, Deborah Vollmer Dahlke, Bradley H. Pollock, and Archie Bleyer, “Comparison of cancer survival trends in the United States of adolescents and young adults with those in children and older adults,” Cancer, 2016. View at Publisher · View at Google Scholar
  • Shan Lin, Roger T. Luo, Anetta Ptasinska, Jon Kerry, Salam A. Assi, Mark Wunderlich, Toshihiko Imamura, Joseph J. Kaberlein, Ahmad Rayes, Mark J. Althoff, John Anastasi, Maureen M. O’Brien, Amom Ruhikanta Meetei, Thomas A. Milne, Constanze Bonifer, James C. Mulloy, and Michael J. Thirman, “Instructive Role of MLL-Fusion Proteins Revealed by a Model of t(4;11) Pro-B Acute Lymphoblastic Leukemia,” Cancer Cell, vol. 30, no. 5, pp. 737–749, 2016. View at Publisher · View at Google Scholar
  • Borhane Guezguez, Mohammed Almakadi, Yannick D. Benoit, Zoya Shapovalova, Susann Rahmig, Aline Fiebig-Comyn, Fanny L. Casado, Borko Tanasijevic, Silvia Bresolin, Riccardo Masetti, Bradley W. Doble, and Mickie Bhatia, “GSK3 Deficiencies in Hematopoietic Stem Cells Initiate Pre-neoplastic State that Is Predictive of Clinical Outcomes of Human Acute Leukemia,” Cancer Cell, vol. 29, no. 1, pp. 61–74, 2016. View at Publisher · View at Google Scholar
  • Eric R. Lechman, Bernhard Gentner, Stanley W.K. Ng, Erwin M. Schoof, Peter van Galen, James A. Kennedy, Silvia Nucera, Fabio Ciceri, Kerstin B. Kaufmann, Naoya Takayama, Stephanie M. Dobson, Aaron Trotman-Grant, Gabriela Krivdova, Janneke Elzinga, Amanda Mitchell, Björn Nilsson, Karin G. Hermans, Kolja Eppert, Rene Marke, Ruth Isserlin, Veronique Voisin, Gary D. Bader, Peter W. Zandstra, Todd R. Golub, Benjamin L. Ebert, Jun Lu, Mark Minden, Jean C.Y. Wang, Luigi Naldini, and John E. Dick, “miR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells,” Cancer Cell, 2016. View at Publisher · View at Google Scholar
  • Irina V. Tiper, and Tonya J. Webb, “Histone deacetylase inhibitors enhance CD1d-dependent NKT cell responses to lymphoma,” Cancer Immunology, Immunotherapy, 2016. View at Publisher · View at Google Scholar
  • Sara J. Schonfeld, Friederike Erdmann, Tracey Wiggill, Elvira Singh, Patricia Kellett, Chantal Babb, and Joachim Schüz, “Hematologic malignancies in South Africa 2000-2006: analysis of data reported to the National Cancer Registry,” Cancer Medicine, 2016. View at Publisher · View at Google Scholar
  • Rouslan Kotchetkov, Esther Masih-Khan, Chia-Min Chu, Eshetu G. Atenafu, Christine Chen, Vishal Kukreti, Suzanne Trudel, Rodger Tiedemann, and Donna E. Reece, “Secondary primary malignancies during the lenalidomide-dexamethasone regimen in relapsed/refractory multiple myeloma patients,” Cancer Medicine, 2016. View at Publisher · View at Google Scholar
  • Hong-Mei Zhang, Qing Li, Xiaojian Zhu, Wei Liu, Hui Hu, Teng Liu, Fanjun Cheng, Yong You, Zhaodong Zhong, Ping Zou, Qiubai Li, Zhichao Chen, and An-Yuan Guo, “miR-146b-5p within BCR-ABL1-Positive Microvesicles Promotes Leukemic Transformation of Hematopoietic Cells,” Cancer Research, vol. 76, no. 10, pp. 2901–2911, 2016. View at Publisher · View at Google Scholar
  • Lydie Ocini Ngolet, Innocent Kocko, and Alexis Elira Dokekias, “Pregnancy and Accelerated Phase of Myeloid Chronic Leukemia Treated with Imatinib: A Case Report from a Developing Country,” Case Reports in Hematology, vol. 2016, pp. 1–3, 2016. View at Publisher · View at Google Scholar
  • Bradley T. Williamson, and Heather A. Leitch, “Higher Risk Myelodysplastic Syndromes in Patients with Well-Controlled HIV Infection: Clinical Features, Treatment, and Outcome,” Case Reports in Hematology, vol. 2016, pp. 1–7, 2016. View at Publisher · View at Google Scholar
  • Sultan S. Aldrees, Pablo Zoroquiain, Sarah A. Alghamdi, Patrick T. Logan, Sonia Callejo, and Miguel N. Burnier, “Conjunctival Involvement of T-Cell Lymphoma in a Patient with Mycosis Fungoides,” Case Reports in Ophthalmological Medicine, vol. 2016, pp. 1–5, 2016. View at Publisher · View at Google Scholar
  • Chunjie Yu, Jiancheng Zeng, Zhenzhen Yan, Zi Ma, Shangqin Liu, and Zan Huang, “Baicalein antagonizes acute megakaryoblastic leukemia in vitro and in vivo by inducing cell cycle arrest,” Cell & Bioscience, vol. 6, no. 1, 2016. View at Publisher · View at Google Scholar
  • Juliane Liepe, Aaron Sim, Helen Weavers, Laura Ward, Paul Martin, and Michael P.H. Stumpf, “Accurate Reconstruction of Cell and Particle Tracks from 3D Live Imaging Data,” Cell Systems, 2016. View at Publisher · View at Google Scholar
  • Tiziana Squillaro, Gianfranco Peluso, and Umberto Galderisi, “Clinical Trials With Mesenchymal Stem Cells: An Update,” Cell Transplantation, vol. 25, no. 5, pp. 829–848, 2016. View at Publisher · View at Google Scholar
  • Yiguo Hu, and Shaoguang Li, “Survival regulation of leukemia stem cells,” Cellular And Molecular Life Sciences, vol. 73, no. 5, pp. 1039–1050, 2016. View at Publisher · View at Google Scholar
  • Thomas Burn, and Jorge Ivan Alvarez, “Reverse transendothelial cell migration in inflammation: to help or to hinder?,” Cellular and Molecular Life Sciences, 2016. View at Publisher · View at Google Scholar
  • Yiming Wang, and Heyu Ni, “Fibronectin maintains the balance between hemostasis and thrombosis,” Cellular and Molecular Life Sciences, vol. 73, no. 17, pp. 3265–3277, 2016. View at Publisher · View at Google Scholar
  • Antonieta Chavez-Gonzalez, Babak Bakhshinejad, Katayoon Pakravan, Monica L. Guzman, and Sadegh Babashah, “Novel strategies for targeting leukemia stem cells: sounding the death knell for blood cancer,” Cellular Oncology, 2016. View at Publisher · View at Google Scholar
  • Mahmoud Labib, Edward H. Sargent, and Shana O. Kelley, “Electrochemical Methods for the Analysis of Clinically Relevant Biomolecules,” Chemical Reviews, 2016. View at Publisher · View at Google Scholar
  • Dalin Hu, Xiaowu Peng, Yungang Liu, Wenjuan Zhang, Xiaochun Peng, Huanwen Tang, Jianhui Yuan, Zhiliang Zhu, and Jianping Yang, “Overexpression of miR-221 in peripheral blood lymphocytes in petrol station attendants: A population based cross-sectional study in southern China,” Chemosphere, vol. 149, pp. 8–13, 2016. View at Publisher · View at Google Scholar
  • R. Shirzad, S. Shahrabi, A. Ahmadzadeh, K. R. Kampen, M. Shahjahani, and N. Saki, “Signaling and molecular basis of bone marrow niche angiogenesis in leukemia,” Clinical and Translational Oncology, 2016. View at Publisher · View at Google Scholar
  • Michael P Cornes, “Exogenous sample contamination. Sources and interference,” Clinical Biochemistry, 2016. View at Publisher · View at Google Scholar
  • Wenyue Hu, Tae Sung, Bart A. Jessen, Stephane Thibault, Martin B. Finkelstein, Nasir K. Khan, and Aida I. Sacaan, “Mechanistic Investigation of Bone Marrow Suppression Associated with Palbociclib and its Differentiation from Cytotoxic Chemotherapies,” Clinical Cancer Research, vol. 22, no. 8, pp. 2000–2008, 2016. View at Publisher · View at Google Scholar
  • Patrícia Andrade, Susana Lopes, and Guilherme Macedo, “Colonic Polyp in a Human Immunodeficiency Virus–Positive Patient: An Unexpected Diagnosis,” Clinical Gastroenterology and Hepatology, 2016. View at Publisher · View at Google Scholar
  • S.M. Nazmus Sakib, and Michael Sadler, “Dramatic treatment response of Cutaneous Plasmablastic Lymphoma in an HIV patient: a case report,” Clinical Imaging, 2016. View at Publisher · View at Google Scholar
  • Theodoros N. Sergentanis, Efstathios Kastritis, Evangelos Terpos, Meletios A. Dimopoulos, and Theodora Psaltopoulou, “Cytogenetics and survival of multiple myeloma: isolated and combined effects,” Clinical Lymphoma Myeloma and Leukemia, 2016. View at Publisher · View at Google Scholar
  • John P. Leonard, Stephanie A. Gregory, Hedy Smith, Thierry J. Horner, Vanessa C. Williams, Patricia Giampietro, and Thomas S. Lin, “CHOP chemotherapy followed by tositumomab and iodine-131 tositumomab for previously untreated diffuse large B-cell lymphoma,” Clinical Lymphoma Myeloma and Leukemia, 2016. View at Publisher · View at Google Scholar
  • Qian Wang, Feng Duan, Ming-xin Wang, Xiao-dong Wang, Peng Liu, and Li-zhi Ma, “Effect of stem cell-based therapy for ischemic stroke treatment: A meta-analysis,” Clinical Neurology and Neurosurgery, vol. 146, pp. 1–11, 2016. View at Publisher · View at Google Scholar
  • Rosa Fonti, Barbara Salvatore, Amalia De Renzo, Emanuele Nicolai, and Silvana Del Vecchio, “Detection of Leptomeningeal Involvement by 18F-FDG-PET/CT in a Patient With Non-Hodgkin Lymphoma,” Clinical Nuclear Medicine, vol. 41, no. 2, pp. 169–172, 2016. View at Publisher · View at Google Scholar
  • Oluwatoyin F. Bamgbola, “Spectrum of anemia after kidney transplantation: pathophysiology and therapeutic implications,” Clinical Transplantation, 2016. View at Publisher · View at Google Scholar
  • Jin Yang, Sanyi Tang, and Robert A. Cheke, “The regulatory system for diabetes mellitus: Modeling rates of glucose infusions and insulin injections,” Communications In Nonlinear Science And Numerical Simulation, vol. 37, pp. 305–325, 2016. View at Publisher · View at Google Scholar
  • Julia Jellusova, and Robert C. Rickert, “The PI3K pathway in B cell metabolism,” Critical Reviews in Biochemistry and Molecular Biology, pp. 1–20, 2016. View at Publisher · View at Google Scholar
  • Xiaohong Ruby Xu, Dan Zhang, Brigitta Elaine Oswald, Naadiya Carrim, Xiaozhong Wang, Yan Hou, Qing Zhang, Christopher Lavalle, Thomas McKeown, Alexandra H. Marshall, and Heyu Ni, “Platelets are versatile cells: New discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond,” Critical Reviews in Clinical Laboratory Sciences, pp. 1–22, 2016. View at Publisher · View at Google Scholar
  • Usha Gutti, Satya Ratan Pasupuleti, Itishri Sahu, Aneesh Kotipalli, Ram Babu Undi, Ravinder Kandi, Raja Gopal Venakata Saladi, and Ravi Kumar Gutti, “Erythropoietin and thrombopoietin mimetics: Natural alternatives to erythrocyte and platelet disorders,” Critical Reviews in Oncology/Hematology, 2016. View at Publisher · View at Google Scholar
  • Anh Phan, Rachel Veldman, and Mary Jo Lechowicz, “T-cell Lymphoma Epidemiology: the Known and Unknown,” Current Hematologic Malignancy Reports, vol. 11, no. 6, pp. 492–503, 2016. View at Publisher · View at Google Scholar
  • Sonia Rey, Visila Moiche, Sebastian Boltaña, Mariana Teles, and Simon MacKenzie, “Behavioural fever in zebrafish larvae,” Developmental & Comparative Immunology, 2016. View at Publisher · View at Google Scholar
  • Hany Sakr, Michael Cruise, Prabhleen Chahal, Claudiu Cotta, James Cook, Sricharan Chalikonda, Steven Rosenblatt, Fatima Hamadeh, Omar Al-Nourhji, and Charles D. Sturgis, “Anaplastic lymphoma kinase positive large B-cell lymphoma: Literature review and report of an endoscopic fine needle aspiration case with tigroid backgrounds mimicking seminoma,” Diagnostic Cytopathology, 2016. View at Publisher · View at Google Scholar
  • Qinghua Cao, Fang Liu, Shurong Li, Ni Liu, Lihui Li, Changzhao Li, and Tingsheng Peng, “Primary rare anaplastic large cell lymphoma, ALK positive in small intestine: case report and review of the literature,” Diagnostic Pathology, vol. 11, no. 1, 2016. View at Publisher · View at Google Scholar
  • Anne L. Robertson, Nikolay V. Ogryzko, Katherine M. Henry, Catherine A. Loynes, Matthew J. Foulkes, Marco M. Meloni, Xingang Wang, Christopher Ford, Malcolm Jackson, Philip W. Ingham, Heather L. Wilson, Stuart N. Farrow, Roberto Solari, Roderick J. Flower, Simon Jones, Moira K. B. Whyte, and Stephen A. Renshaw, “Identification of benzopyrone as a common structural feature in compounds with anti-inflammatory activity in a zebrafish phenotypic screen,” Disease Models & Mechanisms, vol. 9, no. 6, pp. 621–632, 2016. View at Publisher · View at Google Scholar